Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Anthony, arose, aten, Averett, blockade, bone, box, broader, Caracciolo, chronic, circumvented, CMO, Codification, collusion, content, COSO, crucial, decision, deferral, degree, Department, deteriorate, deterioration, developmental, diminishing, DOJ, door, drop, eighteen, EPS, error, fact, False, faulty, float, fluctuated, Frameworkissued, fraud, freestanding, GMP, growth, indefinite, inflammation, inInternal, Inspector, Justice, leukocyte, liable, marrow, Medicaid, Medicare, migration, moderately, movement, multiple, nonaccountable, objective, OIG, override, package, progression, proportion, proportionately, reaction, recharacterize, rejection, relapsed, renegotiated, reproducible, resource, reverse, rheumatoid, roll, rollover, shelf, split, successor, Sunshine, surpassed, survival, team, thereon, thirty, trafficking, underway, unexercised, unqualified, UpdateNo, uplisting, user, vendor, warrantholder, Warren, white
Removed:
accurate, CEO, certified, CFO, CLIA, consisted, corrected, counterparty, deficiency, delivered, description, diversify, earlier, earn, encountered, exhibit, expressing, feline, Florida, formation, formed, Genetic, inhibit, Jacobson, Medicine, mentioned, mitigate, Radiological, reached, reliable, reliably, remedy, replication, retail, strategically, subsidiary, trend, Veterinary
Filing tables
Filing exhibits
CYDY similar filings
Filing view
External links
Exhibit 23
CONSENT OF WARREN AVERETT, LLC
Independent Registered Certified Public Accountants
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-206813) and Registration Statements on Form S-3 (Nos. 333-213349 and 333-213866) of our report dated July 19, 2017 and July 19, 2016, with respect to the consolidated financial statements of CytoDyn Inc. (the “Company”) appearing in this Annual Report on Form 10-K for the years ended May 31, 2017 and 2016.
/s/ Warren Averett, LLC
Warren Averett, LLC
Tampa, Florida
July 19, 2017